MicroRNA machinery

May 25, 2020

https://www.frontiersin.org/articles/10.3389/fonc.2014.00113/full

https://tbsnews.net/environment/cyclone-amphan/un-chief-praises-bangladesh-india-life-saving-work-ahead-cyclone-amphan

https://reliefweb.int/report/bangladesh/needs-assessment-working-group-bangladesh-cyclone-amphan-preliminary-impacts-and

https://edition.cnn.com/2020/05/18/asia/cyclone-amphan-india-bangladesh-intl-hnk/index.html

Pharmacol Res. 2020 Apr 26:104827. doi: 10.1016/j.phrs.2020.104827. [Epub ahead of print]
Tetrahydrobiopterin in energy metabolism and metabolic diseases.
Kim HK1, Han J2.
Author information
Abstract

Tetrahydrobiopterin (BH4) is an endogenous cofactor for various enzymatic conversions of essential biomolecules including nitric oxide, tyrosine, dopamine, serotonin and phenylalanine. Depending on the physiological functions of these molecules, BH4 plays multiple roles in the cardiovascular, immune, nervous and endocrine systems. A deficiency of BH4 or an imbalance of the redox state of biopterin has been implicated in various cardiovascular and metabolic diseases. Therefore, supplementation with BH4 is considered as a therapeutic option for these diseases. In addition to the classical nitric oxide synthase (NOS)-dependent role of BH4, recent studies proposed novel NOS-independent roles of BH4 in health and disease conditions. This article reviews the updated role of BH4 in mitochondrial regulation, energy metabolism and cardiovascular and metabolic diseases.

Copyright © 2020. Published by Elsevier Ltd.
KEYWORDS:

Tetrahydrobiopterin; cardiovascular diseases; energy metabolism; mitochondria

PMID:
32348841
DOI:
10.1016/j.phrs.2020.104827

https://www.mdpi.com/1422-0067/20/15/3841/htm

Role of Carbonic Anhydrases and Inhibitors in Acid–Base Physiology: Insights from Mathematical Modeling

 

Trending Articles
PubMed records with recent increases in activity

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
JAMA. 2020.
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
Int Arch Allergy Immunol. 2020.
SARS-CoV-2 (COVID-19): What do we know about children? A systematic review.
Clin Infect Dis. 2020.
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.
Elife. 2020.
Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.
JAMA Pediatr. 2020.

See more

https://advances.sciencemag.org/content/5/12/eaaw3851

Research ArticleSYSTEMS BIOLOGY
Single-cell connectomic analysis of adult mammalian lungs

See all authors and affiliations

Science Advances  04 Dec 2019:
Vol. 5, no. 12, eaaw3851
DOI: 10.1126/sciadv.aaw3851

Trending Articles
PubMed records with recent increases in activity

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.
Cell. 2020.
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.
Ann Intern Med. 2020.
SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate.
Int J Clin Pract. 2020.
Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.
Cardiovasc Pathol. 2020.
‘All In’: A Pragmatic Framework for COVID-19 Testing and Action on a Global Scale.
EMBO Mol Med. 2020.

See more

https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-2292-6

Leabright's Blog

Just another WordPress.com weblog

WordPress.com

WordPress.com is the best place for your personal blog or business site.